How much do we know about the metastatic process?

Area of Science:

• Oncology
• Cancer Biology
• Metastasis Research

Background:

• Disseminated cancer cells (DCCs) can spread early and enter a dormant state.
• Dormant DCCs evade current therapies targeting primary tumors.
• Detection of DCCs is associated with poor patient survival.

Purpose of the Study:

• To review current methods for detecting DCCs.
• To highlight novel strategies targeting dormant DCCs as minimal residual disease.
• To discuss the role of DCCs in early-stage metastasis and dissemination mechanisms.

Main Methods:

• Review of existing literature on DCC detection and targeting.
• Analysis of evidence on the clinical relevance of early-stage DCCs.
• Discussion of animal models for studying DCCs.
• Exploration of epithelial-mesenchymal transition (EMT) in cancer cell dissemination.

Main Results:

• DCCs can persist in a dormant state, posing a challenge for current treatments.
• Targeting dormant DCCs is crucial for preventing metastasis and reducing minimal residual disease.
• Understanding dissemination mechanisms, including EMT, is key to developing new therapies.

Conclusions:

• Current therapies are insufficient to eradicate dormant DCCs.
• New therapeutic strategies are needed to target DCCs and prevent metastatic recurrence.
• Further research into DCC biology and their interaction with the tumor microenvironment is essential.